Albatroz Therapeutics soars into Johnson & Johnson Innovation
By joining JLABS Singapore, Albatroz gains access to an ecosystem that will expedite the translation of its scientific discoveries.
top of page
Adventure Log
/lɑɡ/
a detailed record of a voyage over a period of time
Nov 9, 2023
Two national appointments for Outram Bio partner Choon Peng Ng
Choon Peng Ng, Outram Bio partner, has been appointed to two national councils to help accelerate Singapore research towards the clinic.
Oct 17, 2023
Albatroz featured as one of six leading biotech companies in Singapore
Labiotech.eu, a leading European biotech publication, lists Albatroz as an emerging leader in Singapore's biotechnology industry.
Apr 25, 2023
Outram Bio leads US$3 million investment in Albatroz Therapeutics
Albatroz is developing therapies to combat extracellular matrix degradation, a key contributor to cancer and arthritis.
Apr 19, 2023
Outram Bio presents at SingHealth Duke-NUS AMRI Research Grand Rounds
Chris and Choon share practical steps towards commercializing research with 200+ biomedical community members.
Mar 19, 2023
Albatroz Therapeutics wins Amgen Golden Ticket award
Amgen and NSG Biolabs announce Albatroz as winner of the first Amgen Golden Ticket in Singapore.
Dec 9, 2022
Professor Hong Wanjin receives President's Science & Technology Medal
Prof Hong is Executive Director at IMCB and scientific advisor to Outram Bio.
Nov 22, 2022
Dr. Andreas Wallnöfer receives Singapore's Public Service Medal
Dr Wallnöfer is Senior Advisor at EDDC and industry advisor to Outram Bio.
Oct 21, 2022
Outram Bio conducts Pitching 101 session at A*STAR
Choon and Chris share their insights with A*STAR researchers on how to make more impactful pitches.
bottom of page